Logo - springer
Slogan - springer

| Drugs - Real World Outcomes (Editorial Board)

We’re working on a new version of this journal site - preview it now
Drugs - Real World Outcomes

Drugs - Real World Outcomes

Editor-in-Chief: Dene Peters
Deputy Editor: Kathy Fraser

ISSN: 2198-9788 (electronic version)

Journal no. 40801

Editors (Adis International Limited, Auckland, New Zealand):

Dene Peters (Editor-in-Chief)

Kathy Fraser (Deputy Editor)

Editorial Board:

G.C. Alexander, Johns Hopkins University, Baltimore, MD, USA

A. Beresniak, Data Mining International, Geneva, Switzerland 

H. Birnbaum, Analysis Group, Inc., Boston, MA, USA

J. Bottomley, Amygdala Ltd., Letchworth Garden City, England

P. Denig, University of Groningen, Groningen, The Netherlands

J.E. Fincham, Presbyterian College School of Pharmacy, Clinton, SC, USA

B. Godman, Karolinska Institutet, Stockholm, Sweden

D. Goldsmith, Goldsmith Pharmacovigilance and Systems, New York, NY, USA

S. Karve, AbbVie, Chicago, IL, USA

N.Y. Kirson, Analysis Group, Inc., Boston, MA, USA

C. Kozma, CK Consulting Associates, St. Helena Island, SC, USA

T. Lasky, U.S. Food and Drug Administration, Silver Spring, MD, USA

A.A. Mangoni, Flinders University, Adelaide, SA, Australia

S. Mimica-Matanovic, University Hospital Osijek, Osijek, Croatia

P.G. Parmar, Auckland University of Technology, Auckland, New Zealand

B. Rinaldi, University of Capania Luigi Vanvitelli, Naples, Italy

J.K. Sluggett, Monash University, Parkville, VIC, Australia

K.A. Swanson, University of Oklahoma, Oklahoma City, OK, USA

J.E Ware Jr., John Ware Research Group Incorporated, Watertown, MA, USA

Q. Zou, Medstar Health Research Institute, Washington, DC, USA

For authors and editors

  • Aims and Scope

    Aims and Scope


    Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas:

    • Using registries/databases/health records and other non-selected observational datasets to investigate:
      • drug use and treatment outcomes

      • prescription patterns

      • drug safety signals

      • adherence to treatment guidelines

      • benefit : risk profiles

      • comparative effectiveness

      • economic analyses including cost-of-illness

    • Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’

    • Techniques and approaches to optimise real-world modelling.

    Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility,readership and educational value of the journal’s content. In addition, articles published in Drugs - Real World Outcomes may be accompanied by plain language summaries to assist readers in understanding important medical advances.

  • Submit Online
  • Instructions for Authors

    Instructions for Authors


  • Important Information for Authors

    Important Information for Authors


  • Compliance with Ethical Policies
  • Conflict of Interest form (doc, 84 kB)
  • Copyright Information

    Copyright Information


    Copyright and Licence Agreement

    Open Access Drugs- Real World Outcomes  is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, go to: https://creativecommons. org/licenses/by-nc/4.0

    Journal ownership: Springer International Publishing Switzerland

     Copyright of articles: © The Author(s)

Alerts for this journal


Get the table of contents of every new issue published in Drugs - Real World Outcomes.

Additional information